Aptorum Group Limited (NASDAQ:APM) Short Interest Down 49.3% in February

Aptorum Group Limited (NASDAQ:APM) saw a large decline in short interest in February. As of February 28th, there was short interest totalling 58,500 shares, a decline of 49.3% from the February 13th total of 115,400 shares. Based on an average daily volume of 2,240,000 shares, the short-interest ratio is presently 0.0 days. Approximately 1.3% of the company’s stock are sold short.

Aptorum Group Stock Down 2.6 %

Shares of NASDAQ APM opened at $0.90 on Friday. Aptorum Group has a 52-week low of $0.46 and a 52-week high of $11.95. The firm’s 50-day moving average price is $1.16 and its 200-day moving average price is $1.46.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.